B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a treatment called CAR T-cell therapy for people with advanced B-cell leukemias that haven't responded to standard drugs. Participants' own immune cells are collected, modified to recognize and attack cancer cells, and then returned to the body. The goal is to co…
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 22:35 UTC
-
New antibody drug aims to shield blood cancer patients from life-threatening infections
Disease control Recruiting nowThis study tests whether adding XEMBIFY (an antibody replacement) to standard treatment can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who have low antibody levels and frequent…
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC